I am interested in getting a sense of the competitive landscape of companies that are developing novel delivery systems for chem

Goals

To provide a competitive landscape for two types of novel chemotherapy delivery systems; liposomes and polymeric nanoparticles/ polymeric micelles, in the form of a list of commercial products in each category, as well as determining prominent companies in each category.

Early Findings


Liposome chemotherapy treatments typically involved the chemical liposomal doxorubicin. Liposomal doxorubicin is used for treatment of patients with various cancers, including ovarian, AIDS-related Kaposi's sarcoma, who have already received one alternate type of therapy or who have shown intolerance to other cancer treatments.

Common branded versions of liposomal doxorubicin include Doxil (Janssen), Caelyx (Janssen) or Myocet (Teva).

A generic lower cost version, Lipodox, has also been released.

Liposomal doxorubicin features a protective cellular coating to allow for slower release than traditional doxorubicin, and potentially greater treatment efficacy as it has longer to reach tumor tissue in the body, and is given via IV or injection.

The global liposomal doxorubicin market is experiencing rapid growth due to a growing awareness of the benefits of treatment using the formulation over traditional doxorubicin, with a projected CAGR of 6.2%.

Polymeric nano treatment and polymeric micelle treatments are defined as "chemotherapy mediated by nanotechnology," and are being studied for their increased therapeutic efficiency with lower side effect frequency.

There are many different forms of polymeric nano treatments, which include disulfiram, quercetin, dasatinib, and salinomycin.

Disulfram, one of the key polymeric treatments, also known as antibuse, has been branded by many companies, including Antaethyl (Sanofi), Antalcol (Sintofarm), Anticol (Polfa Warszawa) / and Chronol (Charoon Bhesaj).

Polymeric nano treatment quercetin is a natural treatment combining quercetin, a citrus bioflavonoid, found in many plants and foods, with traditional treatments.


Proposed Next Steps

Given the data we discovered on liposomal treatments and polymeric nanoparticle treatment, we could do (1)competitive landscape on 3-5 of the key brands of liposomal treatment (3 hrs, $75) as well as
(2) a comparison of polymeric nanoparticle treatment types, comparing disulfiram, quercetin, dasatinib, and salinomycin (3 hrs, $75).

We can also provide (3) a list of key companies providing polymeric nanoparticle treatment within any of the types mentioned above (3 hrs, $75).

Given in our preliminary research we found that there is an increasing amount of medical research being done in the area of polymeric nano treatment, you may also be interested in (4) a report which outlines any recent studies on the treatment and its efficacy (3 hrs, $75)

Proposed next steps:

You need to be the project owner to select a next step.